Cancer Biomarkers Market Outlook: Advancements in Early Detection and Diagnosis
The global cancer biomarkers market was valued at USD 30.35 billion in 2023 and is projected to reach USD 69.76 billion by 2030, demonstrating a robust Compound Annual Growth Rate (CAGR) of 12.7% from 2024 to 2030. These biomarkers are critical in determining cancer patient prognosis and play a significant role in diagnosing and treating nearly every patient.   The market's...
0 Comments 0 Shares 32 Views 0 Reviews